基于深度学习的量化在临床0-I期肺腺癌中的预后影响
本研究纳入542例临床0-I期外周型肺腺癌患者,评估深度学习算法自动测量病灶大小、质量与体积预测预后的性能,并与手动测量比较。结果显示深度学习测量的T分期优于放射科医师,对于磨玻璃结节,深度学习以0 HU测量的实性成分质量与体积能有效分层生存风险且为独立危险因素。
要点
- 深度学习自动测量可替代人工进行肺腺癌大小测量,预后分层优于手动测量。
- 对于磨玻璃结节,放射科医师测量的MSSA基于CTR无法分层RFS和OS风险,而深度学习以0 HU测量的2D-AIMSSA0HU%可分层。
- 深度学习以0 HU测量的AISM0HU%和AISV0HU%可有效分层生存风险,且为独立危险因素,优于2D-AIMSSA0HU%。
核心结论
- 深度学习算法可替代人工进行更准确的肺腺癌T分期;对于磨玻璃结节,2D-AIMSSA0HU%可预测预后而RMSSA%不能;AISM0HU%和AISV0HU%的预测效能更准确且均为独立危险因素。
研究设计与样本
- 共纳入542例临床0-I期外周型肺腺癌患者,均有1 mm层厚术前CT数据;由两名胸部放射科医师评估最大实性成分轴向尺寸(MSSA),深度学习评估MSSA、实性成分体积(SV)和实性成分质量(SM),并计算实性成分与肿瘤比值(CTR)。
关键影像表现/征象
- 对于磨玻璃结节,以不同密度水平阈值提取实性部分。
- 放射科医师测量的MSSA基于CTR(RMSSA%)无法分层RFS和OS风险,而深度学习以0 HU测量的2D-AIMSSA0HU%可使用不同截断值进行分层。
- 深度学习以0 HU测量的SM和SV(AISM0HU%和AISV0HU%)无论截断值如何均可有效分层生存风险,且优于2D-AIMSSA0HU%。
诊断标准与关键数值
- 放射科医师测量的T分期预后预测效能劣于深度学习测量的T分期。
- 对于磨玻璃结节,RMSSA%无法分层RFS和OS风险,而2D-AIMSSA0HU%可使用不同截断值分层。
- AISM0HU%和AISV0HU%为独立危险因素。
临床应用与阅片要点
- 深度学习算法可替代人工进行大小测量,在肺腺癌患者中预后分层优于手动测量。
- 对于磨玻璃结节,深度学习以0 HU测量的MSSA基于CTR可分层生存风险,而放射科医师测量的则不能。
- 深度学习以0 HU测量的质量和体积基于CTR的预测效能优于MSSA基于CTR,且两者均为独立危险因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the performance of automatic deep learning (DL) algorithm for size, mass, and volume measurements in predicting prognosis of lung adenocarcinoma (LUAD) and compared with manual measurements.
METHODS: A total of 542 patients with clinical stage 0-I peripheral LUAD and with preoperative CT data of 1-mm slice thickness were included. Maximal solid size on axial image (MSSA) was evaluated by two chest radiologists. MSSA, volume of solid component (SV), and mass of solid component (SM) were evaluated by DL. Consolidation-to-tumor ratios (CTRs) were calculated. For ground glass nodules (GGNs), solid parts were extracted with different density level thresholds. The prognosis prediction efficacy of DL was compared with that of manual measurements. Multivariate Cox proportional hazards model was used to find independent risk factors.
RESULTS: The prognosis prediction efficacy of T-staging (TS) measured by radiologists was inferior to that of DL. For GGNs, MSSA-based CTR measured by radiologists (RMSSA%) could not stratify RFS and OS risk, whereas measured by DL using 0HU (2D-AIMSSA0HU%) could by using different cutoffs. SM and SV measured by DL using 0 HU (AISM0HU% and AISV0HU%) could effectively stratify the survival risk regardless of different cutoffs and were superior to 2D-AIMSSA0HU%. AISM0HU% and AISV0HU% were independent risk factors.
CONCLUSION: DL algorithm can replace human for more accurate T-staging of LUAD. For GGNs, 2D-AIMSSA0HU% could predict prognosis rather than RMSSA%. The prediction efficacy of AISM0HU% and AISV0HU% was more accurate than of 2D-AIMSSA0HU% and both were independent risk factors.
CLINICAL RELEVANCE STATEMENT: Deep learning algorithm could replace human for size measurements and could better stratify prognosis than manual measurements in patients with lung adenocarcinoma.
KEY POINTS: • Deep learning (DL) algorithm could replace human for size measurements and could better stratify prognosis than manual measurements in patients with lung adenocarcinoma (LUAD). • For GGNs, maximal solid size on axial image (MSSA)-based consolidation-to-tumor ratio (CTR) measured by DL using 0 HU could stratify survival risk than that measured by radiologists. • The prediction efficacy of mass- and volume-based CTRs measured by DL using 0 HU was more accurate than of MSSA-based CTR and both were independent risk factors.
引用
- Zhu Y, Chen LL, Luo YW, et al. Prognostic impact of deep learning-based quantification in clinical stage 0-I lung adenocarcinoma. Eur Radiol. 2023. PMID: 37436506. doi:10.1007/s00330-023-09845-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。